<VariationArchive VariationID="1457169" VariationName="NC_000019.9:g.(?_12757434)_(13617038_?)del" VariationType="Deletion" Accession="VCV001457169" Version="8" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="1" DateLastUpdated="2024-07-07" DateCreated="2022-03-28" MostRecentSubmission="2024-06-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1477906" VariationID="1457169">
      <GeneList>
        <Gene Symbol="CALR" FullName="calreticulin" GeneID="811" HGNC_ID="HGNC:1455" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12938609" stop="12944489" display_start="12938609" display_stop="12944489" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13049413" stop="13055303" display_start="13049413" display_stop="13055303" Strand="+" />
          </Location>
          <OMIM>109091</OMIM>
        </Gene>
        <Gene Symbol="DAND5" FullName="DAN domain BMP antagonist family member 5" GeneID="199699" HGNC_ID="HGNC:26780" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12969576" stop="12974760" display_start="12969576" display_stop="12974760" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13080431" stop="13085566" display_start="13080431" display_stop="13085566" Strand="+" />
          </Location>
          <OMIM>609068</OMIM>
        </Gene>
        <Gene Symbol="DHPS" FullName="deoxyhypusine synthase" GeneID="1725" HGNC_ID="HGNC:2869" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12672470" stop="12681880" display_start="12672470" display_stop="12681880" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12786530" stop="12792700" display_start="12786530" display_stop="12792700" Strand="-" />
          </Location>
          <OMIM>600944</OMIM>
        </Gene>
        <Gene Symbol="DNASE2" FullName="deoxyribonuclease 2, lysosomal" GeneID="1777" HGNC_ID="HGNC:2960" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12875209" stop="12881449" display_start="12875209" display_stop="12881449" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12986024" stop="12992334" display_start="12986024" display_stop="12992334" Strand="-" />
          </Location>
          <OMIM>126350</OMIM>
        </Gene>
        <Gene Symbol="FARSA" FullName="phenylalanyl-tRNA synthetase subunit alpha" GeneID="2193" HGNC_ID="HGNC:3592" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12922479" stop="12933711" display_start="12922479" display_stop="12933711" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13033283" stop="13044557" display_start="13033283" display_stop="13044557" Strand="-" />
          </Location>
          <OMIM>602918</OMIM>
        </Gene>
        <Gene Symbol="FBXW9" FullName="F-box and WD repeat domain containing 9" GeneID="84261" HGNC_ID="HGNC:28136" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12688916" stop="12696631" display_start="12688916" display_stop="12696631" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12799729" stop="12807454" display_start="12799729" display_stop="12807454" Strand="-" />
          </Location>
          <OMIM>609074</OMIM>
        </Gene>
        <Gene Symbol="BEST2" FullName="bestrophin 2" GeneID="54831" HGNC_ID="HGNC:17107" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12751791" stop="12758458" display_start="12751791" display_stop="12758458" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12863406" stop="12869271" display_start="12863406" display_stop="12869271" Strand="+" />
          </Location>
          <OMIM>607335</OMIM>
        </Gene>
        <Gene Symbol="CACNA1A" FullName="calcium voltage-gated channel subunit alpha1 A" GeneID="773" HGNC_ID="HGNC:1388" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13206442" stop="13506479" display_start="13206442" display_stop="13506479" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13317255" stop="13617273" display_start="13317255" display_stop="13617273" Strand="-" />
          </Location>
          <OMIM>601011</OMIM>
          <Haploinsufficiency last_evaluated="2017-05-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CACNA1A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2017-05-21" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CACNA1A">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="GADD45GIP1" FullName="GADD45G interacting protein 1" GeneID="90480" HGNC_ID="HGNC:29996" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12953119" stop="12957223" display_start="12953119" display_stop="12957223" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13064969" stop="13068067" display_start="13064969" display_stop="13068067" Strand="-" />
          </Location>
          <OMIM>605162</OMIM>
        </Gene>
        <Gene Symbol="GCDH" FullName="glutaryl-CoA dehydrogenase" GeneID="2639" HGNC_ID="HGNC:4189" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12891129" stop="12899999" display_start="12891129" display_stop="12899999" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13001973" stop="13010782" display_start="13001973" display_stop="13010782" Strand="+" />
          </Location>
          <OMIM>608801</OMIM>
        </Gene>
        <Gene Symbol="GET3" FullName="guided entry of tail-anchored proteins factor 3, ATPase" GeneID="439" HGNC_ID="HGNC:752" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12737106" stop="12748323" display_start="12737106" display_stop="12748323" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12848305" stop="12859136" display_start="12848305" display_stop="12859136" Strand="+" />
          </Location>
          <OMIM>601913</OMIM>
        </Gene>
        <Gene Symbol="HOOK2" FullName="hook microtubule tethering protein 2" GeneID="29911" HGNC_ID="HGNC:19885" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12763003" stop="12792350" display_start="12763003" display_stop="12792350" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12873816" stop="12886433" display_start="12873816" display_stop="12886433" Strand="-" />
          </Location>
          <OMIM>607824</OMIM>
        </Gene>
        <Gene Symbol="IER2" FullName="immediate early response 2" GeneID="9592" HGNC_ID="HGNC:28871" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13150411" stop="13154911" display_start="13150411" display_stop="13154911" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13261281" stop="13265721" display_start="13261281" display_stop="13265721" Strand="+" />
          </Location>
          <OMIM>620036</OMIM>
        </Gene>
        <Gene Symbol="JUNB" FullName="JunB proto-oncogene, AP-1 transcription factor subunit" GeneID="3726" HGNC_ID="HGNC:6205" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12791486" stop="12793315" display_start="12791486" display_stop="12793315" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12902309" stop="12904124" display_start="12902309" display_stop="12904124" Strand="+" />
          </Location>
          <OMIM>165161</OMIM>
        </Gene>
        <Gene Symbol="KLF1" FullName="KLF transcription factor 1" GeneID="10661" HGNC_ID="HGNC:6345" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12884422" stop="12887201" display_start="12884422" display_stop="12887201" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12995235" stop="12998016" display_start="12995235" display_stop="12998016" Strand="-" />
          </Location>
          <OMIM>600599</OMIM>
        </Gene>
        <Gene Symbol="LYL1" FullName="LYL1 basic helix-loop-helix family member" GeneID="4066" HGNC_ID="HGNC:6734" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13099033" stop="13102858" display_start="13099033" display_stop="13102858" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13209841" stop="13213973" display_start="13209841" display_stop="13213973" Strand="-" />
          </Location>
          <OMIM>151440</OMIM>
        </Gene>
        <Gene Symbol="MAN2B1" FullName="mannosidase alpha class 2B member 1" GeneID="4125" HGNC_ID="HGNC:6826" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12646512" stop="12666742" display_start="12646512" display_stop="12666742" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12757321" stop="12777590" display_start="12757321" display_stop="12777590" Strand="-" />
          </Location>
          <OMIM>609458</OMIM>
        </Gene>
        <Gene Symbol="MAST1" FullName="microtubule associated serine/threonine kinase 1" GeneID="22983" HGNC_ID="HGNC:19034" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12838515" stop="12874952" display_start="12838515" display_stop="12874952" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12949258" stop="12985765" display_start="12949258" display_stop="12985765" Strand="+" />
          </Location>
          <OMIM>612256</OMIM>
        </Gene>
        <Gene Symbol="NACC1" FullName="nucleus accumbens associated 1" GeneID="112939" HGNC_ID="HGNC:20967" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13116852" stop="13141147" display_start="13116852" display_stop="13141147" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13229101" stop="13251960" display_start="13229101" display_stop="13251960" Strand="+" />
          </Location>
          <OMIM>610672</OMIM>
        </Gene>
        <Gene Symbol="NFIX" FullName="nuclear factor I X" GeneID="4784" HGNC_ID="HGNC:7788" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12995475" stop="13098796" display_start="12995475" display_stop="13098796" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13106583" stop="13209609" display_start="13106583" display_stop="13209609" Strand="+" />
          </Location>
          <OMIM>164005</OMIM>
          <Haploinsufficiency last_evaluated="2022-04-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NFIX">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-04-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NFIX">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="PRDX2" FullName="peroxiredoxin 2" GeneID="7001" HGNC_ID="HGNC:9353" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12796823" stop="12801800" display_start="12796823" display_stop="12801800" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12907633" stop="12912693" display_start="12907633" display_stop="12912693" Strand="-" />
          </Location>
          <OMIM>600538</OMIM>
        </Gene>
        <Gene Symbol="RAD23A" FullName="RAD23 homolog A, nucleotide excision repair protein" GeneID="5886" HGNC_ID="HGNC:9812" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12945862" stop="12953642" display_start="12945862" display_stop="12953642" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13056627" stop="13064456" display_start="13056627" display_stop="13064456" Strand="+" />
          </Location>
          <OMIM>600061</OMIM>
        </Gene>
        <Gene Symbol="RNASEH2A" FullName="ribonuclease H2 subunit A" GeneID="10535" HGNC_ID="HGNC:18518" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12806584" stop="12813640" display_start="12806584" display_stop="12813640" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12917427" stop="12924461" display_start="12917427" display_stop="12924461" Strand="+" />
          </Location>
          <OMIM>606034</OMIM>
        </Gene>
        <Gene Symbol="RTBDN" FullName="retbindin" GeneID="83546" HGNC_ID="HGNC:30310" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12825482" stop="12835428" display_start="12825482" display_stop="12835428" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12936290" stop="12946241" display_start="12936290" display_stop="12946241" Strand="-" />
          </Location>
          <OMIM>609553</OMIM>
        </Gene>
        <Gene Symbol="STX10" FullName="syntaxin 10" GeneID="8677" HGNC_ID="HGNC:11428" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13144058" stop="13150375" display_start="13144058" display_stop="13150375" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13255223" stop="13260986" display_start="13255223" display_stop="13260986" Strand="-" />
          </Location>
          <OMIM>603765</OMIM>
        </Gene>
        <Gene Symbol="SYCE2" FullName="synaptonemal complex central element protein 2" GeneID="256126" HGNC_ID="HGNC:27411" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12898786" stop="12919293" display_start="12898786" display_stop="12919293" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13009893" stop="13030085" display_start="13009893" display_stop="13030085" Strand="-" />
          </Location>
          <OMIM>611487</OMIM>
        </Gene>
        <Gene Symbol="TNPO2" FullName="transportin 2" GeneID="30000" HGNC_ID="HGNC:19998" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12699201" stop="12723932" display_start="12699201" display_stop="12723932" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12810007" stop="12834809" display_start="12810007" display_stop="12834809" Strand="-" />
          </Location>
          <OMIM>603002</OMIM>
        </Gene>
        <Gene Symbol="TRIR" FullName="telomerase RNA component interacting RNase" GeneID="79002" HGNC_ID="HGNC:28424" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12730640" stop="12734684" display_start="12730640" display_stop="12734684" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12841453" stop="12845528" display_start="12841453" display_stop="12845528" Strand="-" />
          </Location>
        </Gene>
        <Gene Symbol="TRMT1" FullName="tRNA methyltransferase 1" GeneID="55621" HGNC_ID="HGNC:25980" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="13104907" stop="13116740" display_start="13104907" display_stop="13116740" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13215713" stop="13227562" display_start="13215713" display_stop="13227562" Strand="-" />
          </Location>
          <OMIM>611669</OMIM>
        </Gene>
        <Gene Symbol="WDR83" FullName="WD repeat domain 83" GeneID="84292" HGNC_ID="HGNC:32672" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12666807" stop="12675832" display_start="12666807" display_stop="12675832" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12777617" stop="12786645" display_start="12777617" display_stop="12786645" Strand="+" />
          </Location>
          <OMIM>616850</OMIM>
        </Gene>
        <Gene Symbol="WDR83OS" FullName="WD repeat domain 83 opposite strand" GeneID="51398" HGNC_ID="HGNC:30203" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12668073" stop="12669415" display_start="12668073" display_stop="12669415" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12778880" stop="12780464" display_start="12778880" display_stop="12780464" Strand="-" />
          </Location>
          <OMIM>618474</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000019.9:g.(?_12757434)_(13617038_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" innerStart="12757434" innerStop="13617038" display_start="12757434" display_stop="13617038" variantLength="859605" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.(?_12757434)_(13617038_?)del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.(?_12757434)_(13617038_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000019.9:g.(?_12757434)_(13617038_?)del AND Glutaric aciduria, type 1" Accession="RCV001947065" Version="5">
        <ClassifiedConditionList TraitSetID="530">
          <ClassifiedCondition DB="MedGen" ID="C0268595">Glutaric aciduria, type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000019.9:g.(?_12757434)_(13617038_?)del AND multiple conditions" Accession="RCV001953618" Version="4">
        <ClassifiedConditionList TraitSetID="39917">
          <ClassifiedCondition DB="MedGen" ID="C4310716">Developmental and epileptic encephalopathy, 42</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1720416">Episodic ataxia type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000019.9:g.(?_12757434)_(13617038_?)del AND Aicardi-Goutieres syndrome 4" Accession="RCV004579585" Version="1">
        <ClassifiedConditionList TraitSetID="1274">
          <ClassifiedCondition DB="MedGen" ID="C1835912">Aicardi-Goutieres syndrome 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-08" NumberOfSubmissions="3" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-06-29">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10371528</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10699052</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11854167</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16602100</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19486177</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21454563</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25274781</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25735478</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27250579</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="39917" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36150" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 42</ElementValue>
                <XRef ID="MONDO:0014917" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epileptic encephalopathy, early infantile, 42</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DEE42</ElementValue>
                <XRef Type="MIM" ID="617106" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16191" />
                <XRef ID="16191" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C4310716" DB="MedGen" />
              <XRef ID="MONDO:0014917" DB="MONDO" />
              <XRef Type="MIM" ID="617106" DB="OMIM" />
            </Trait>
            <Trait ID="1620" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Episodic ataxia with nystagmus</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nystagmus-associated episodic ataxia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Episodic ataxia type 2</ElementValue>
                <XRef ID="Episodic+Ataxia+with+Nystagmus/2620" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007163" DB="MONDO" />
                <XRef ID="420932006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebellopathy, hereditary paroxysmal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia, familial, paroxysmal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acetazolamide-responsive, hereditary, paroxysmal, cerebellar ataxia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Acetazolamide-responsive episodic ataxia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebellar ataxia, paroxysmal, Acetazolamide-responsive</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EA2</ElementValue>
                <XRef Type="MIM" ID="108500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">APCA</ElementValue>
                <XRef Type="MIM" ID="108500" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CAPA</ElementValue>
                <XRef Type="MIM" ID="108500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9602" />
                <XRef ID="9602" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301317</ID>
                <ID Source="BookShelf">NBK1138</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20050888</ID>
              </Citation>
              <XRef ID="97" DB="Orphanet" />
              <XRef ID="C1720416" DB="MedGen" />
              <XRef ID="MONDO:0007163" DB="MONDO" />
              <XRef Type="MIM" ID="108500" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="530" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2233" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Glutaric aciduria, type 1</ElementValue>
                <XRef ID="76175005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GA I</ElementValue>
                <XRef Type="MIM" ID="231670" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glutaricaciduria, type I</ElementValue>
                <XRef ID="INHP_45_1" DB="Ege University Pediatric Genetics, Ege University" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glutaryl-CoA dehydrogenase deficiency</ElementValue>
                <XRef ID="MONDO:0009281" DB="MONDO" />
                <XRef ID="360416003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glutaric acidemia type I</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glutaricacidemia Type 1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">GA 1</ElementValue>
                <XRef ID="76175005" DB="SNOMED CT" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6522" />
                <XRef ID="6522" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of untreated glutaric acidemia type 1 (GA-1) ranges from the more common form (infantile-onset disease) to the less common form (later-onset disease – i.e., after age 6 years). Of note, the GA-1 phenotype can vary widely between untreated family members with the same genotype, primarily as a function of the age at which the first acute encephalopathic crisis occurred: three months to six years in infantile-onset GA-1 and after age six years in later-onset GA-1. Characteristically these crises result in acute bilateral striatal injury and subsequent complex movement disorders. In the era of newborn screening (NBS), the prompt initiation of treatment of asymptomatic infants detected by NBS means that most individuals who would have developed manifestations of either infantile-onset or later-onset GA-1 remain asymptomatic; however, they may be at increased risk for other manifestations (e.g., renal disease) that are becoming apparent as the understanding of the natural history of treated GA-1 continues to evolve.</Attribute>
                <XRef ID="NBK546575" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31536184</ID>
                <ID Source="BookShelf">NBK546575</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C5-DC.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C5-DC Acylcarnitine, Glutaric Acidemia Type I (GA I), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C5-DC-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Glutaric Acidemia Type I (GA I): Elevated C5-DC, 2022</CitationText>
              </Citation>
              <XRef ID="25" DB="Orphanet" />
              <XRef ID="C0268595" DB="MedGen" />
              <XRef ID="MONDO:0009281" DB="MONDO" />
              <XRef Type="MIM" ID="231670" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1274" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="191" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Aicardi-Goutieres syndrome 4</ElementValue>
                <XRef ID="MONDO:0012472" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AGS4</ElementValue>
                <XRef Type="MIM" ID="610333" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15480" />
                <XRef ID="15480" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10896" />
                <XRef ID="10896" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Most characteristically, Aicardi-Goutières syndrome (AGS) manifests as an early-onset encephalopathy that usually, but not always, results in severe intellectual and physical disability. A subgroup of infants with AGS present at birth with abnormal neurologic findings, hepatosplenomegaly, elevated liver enzymes, and thrombocytopenia, a picture highly suggestive of congenital infection. Otherwise, most affected infants present at variable times after the first few weeks of life, frequently after a period of apparently normal development. Typically, they demonstrate the subacute onset of a severe encephalopathy characterized by extreme irritability, intermittent sterile pyrexias, loss of skills, and slowing of head growth. Over time, as many as 40% develop chilblain skin lesions on the fingers, toes, and ears. It is becoming apparent that atypical, sometimes milder, cases of AGS exist, and thus the true extent of the phenotype associated with pathogenic variants in the AGS-related genes is not yet known.</Attribute>
                <XRef ID="NBK1475" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301648</ID>
                <ID Source="BookShelf">NBK1475</ID>
              </Citation>
              <XRef ID="51" DB="Orphanet" />
              <XRef ID="C1835912" DB="MedGen" />
              <XRef ID="MONDO:0012472" DB="MONDO" />
              <XRef Type="MIM" ID="610333" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4258575" SubmissionDate="2023-02-03" DateLastUpdated="2023-11-11" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NM_001127221.1_19_Deletion (entire coding sequence)|MedGen:C4310716;C1720416" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002240705" DateUpdated="2023-11-11" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10371528</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19486177</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25735478</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27250579</ID>
          </Citation>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the CACNA1A gene has been identified. Loss-of-function variants in CACNA1A are known to be pathogenic (PMID: 10371528, 19486177, 25735478, 27250579). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes. This variant has not been reported in the literature in individuals affected with CACNA1A-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CACNA1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.(?_12757434)_(13617038_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4310716" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1720416" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4265085" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NM_000159.3_19_Deletion (entire coding sequence)|MedGen:C0268595" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002244273" DateUpdated="2024-06-09" DateCreated="2022-03-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10699052</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11854167</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16602100</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with GCDH-related conditions. A gross deletion of the genomic region encompassing the full coding sequence of the GCDH gene has been identified. Loss-of-function variants in GCDH are known to be pathogenic (PMID: 10699052, 11854167, 16602100). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GCDH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.(?_12757434)_(13617038_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268595" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9838998" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-29" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NC_000019.9:g.(?_12757434)_(13617038_?)del|MedGen:C1835912" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005063619" DateUpdated="2024-06-29" DateCreated="2024-06-29" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21454563</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25274781</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with RNASEH2A-related conditions. A gross deletion of the genomic region encompassing the full coding sequence of the RNASEH2A gene has been identified. Loss-of-function variants in RNASEH2A are known to be pathogenic (PMID: 21454563, 25274781). The boundaries of this event are unknown as they extend beyond the assayed region for this gene and therefore may encompass additional genes.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.(?_12757434)_(13617038_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1835912" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14505471</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4265085" TraitType="Disease" MappingType="XRef" MappingValue="C0268595" MappingRef="MedGen">
        <MedGen CUI="C0268595" Name="Glutaric aciduria, type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4258575" TraitType="Disease" MappingType="XRef" MappingValue="C1720416" MappingRef="MedGen">
        <MedGen CUI="C1720416" Name="Episodic ataxia type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9838998" TraitType="Disease" MappingType="XRef" MappingValue="C1835912" MappingRef="MedGen">
        <MedGen CUI="C1835912" Name="Aicardi-Goutieres syndrome 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4258575" TraitType="Disease" MappingType="XRef" MappingValue="C4310716" MappingRef="MedGen">
        <MedGen CUI="C4310716" Name="Developmental and epileptic encephalopathy, 42" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

